Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Treatment of relapsing polychondritis

Clement J Michet, MD
Section Editor
Peter H Schur, MD
Deputy Editor
Paul L Romain, MD


It is difficult to predict the clinical course of relapsing polychondritis (RPC) because there is a marked inter-patient variability (see "Clinical manifestations of relapsing polychondritis") The patterns that may be seen include:

Episodic disease activity.

Smoldering disease with ever-changing severity.

A fulminant downhill course resulting in death.

A relatively benign course that is free of clinically evident visceral involvement and is easily managed. It is not possible to estimate the prevalence of this self-limited pattern, since it is likely that many of these cases are not diagnosed.

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Dec 29, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Khan GA, Glicklich DG, Iskaros BF, Posner L. Relapsing polychondritis occurring de novo in a renal transplant patient. Transplantation 1994; 58:737.
  2. Yamashita H, Takahashi H, Kubota K, et al. Utility of fluorodeoxyglucose positron emission tomography/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review. Rheumatology (Oxford) 2014; 53:1482.
  3. Buckley LM, Ades PA. Progressive aortic valve inflammation occurring despite apparent remission of relapsing polychondritis. Arthritis Rheum 1992; 35:812.
  4. Arnaud L, Devilliers H, Peng SL, et al. The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. Autoimmun Rev 2012; 12:204.
  5. Ridgway HB, Hansotia PL, Schorr WF. Relapsing polychondritis: unusual neurological findings and therapeutic efficacy of dapsone. Arch Dermatol 1979; 115:43.
  6. Damiani JM, Levine HL. Relapsing polychondritis--report of ten cases. Laryngoscope 1979; 89:929.
  8. Dolan DL, Lemmon GB Jr, Teitelbaum SL. Relapsing polychondritis. Analytical literature review and studies on pathogenesis. Am J Med 1966; 41:285.
  9. Askari AD. Colchicine for treatment of relapsing polychondritis. J Am Acad Dermatol 1984; 10:507.
  10. Mark KA, Franks AG Jr. Colchicine and indomethacin for the treatment of relapsing polychondritis. J Am Acad Dermatol 2002; 46:S22.
  11. Hoang-Xaun T, Foster CS, Rice BA. Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology 1990; 97:892.
  12. Ruhlen JL, Huston KA, Wood WG. Relapsing polychondritis with glomerulonephritis. Improvement with prednisone and cyclophosphamide. JAMA 1981; 245:847.
  13. Chang-Miller A, Okamura M, Torres VE, et al. Renal involvement in relapsing polychondritis. Medicine (Baltimore) 1987; 66:202.
  14. Stewart KA, Mazanec DJ. Pulse intravenous cyclophosphamide for kidney disease in relapsing polychondritis. J Rheumatol 1992; 19:498.
  15. Trepel RJ, Lipnick RN, D'Angelo L. Relapsing polychondritis in an adolescent. J Adolesc Health Care 1989; 10:557.
  16. Hughes RA, Berry CL, Seifert M, Lessof MH. Relapsing polychondritis. Three cases with a clinico-pathological study and literature review. Q J Med 1972; 41:363.
  17. Irani BS, Martin-Hirsch DP, Clark D, et al. Relapsing polychondritis--a study of four cases. J Laryngol Otol 1992; 106:911.
  18. Ormerod AD, Clark LJ. Relapsing polychondritis--treatment with cyclosporin A. Br J Dermatol 1992; 127:300.
  19. Priori R, Paroli MP, Luan FL, et al. Cyclosporin A in the treatment of relapsing polychondritis with severe recurrent eye involvement. Br J Rheumatol 1993; 32:352.
  20. Lipnick RN, Fink CW. Acute airway obstruction in relapsing polychondritis: treatment with pulse methylprednisolone. J Rheumatol 1991; 18:98.
  21. Park J, Gowin KM, Schumacher HR Jr. Steroid sparing effect of methotrexate in relapsing polychondritis. J Rheumatol 1996; 23:937.
  22. Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129:114.
  23. Richez C, Dumoulin C, Coutouly X, Schaeverbeke T. Successful treatment of relapsing polychondritis with infliximab. Clin Exp Rheumatol 2004; 22:629.
  24. Cazabon S, Over K, Butcher J. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye (Lond) 2005; 19:222.
  25. Carter JD. Treatment of relapsing polychondritis with a TNF antagonist. J Rheumatol 2005; 32:1413.
  26. Kawai M, Hagihara K, Hirano T, et al. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis. Rheumatology (Oxford) 2009; 48:318.
  27. Wallace ZS, Stone JH. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade. J Rheumatol 2013; 40:100.
  28. Tyndall A. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus. J Rheumatol Suppl 1997; 48:94.
  29. Rosen O, Thiel A, Massenkeil G, et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000; 2:327.
  30. Kötter I, Daikeler T, Amberger C, et al. Autologous stem cell transplantation of treatment-resistant systemic vasculitis--a single center experience and review of the literature. Clin Nephrol 2005; 64:485.
  31. Goldenberg G, Sangueza OP, Jorizzo JL. Successful treatment of relapsing polychondritis with mycophenolate mofetil. J Dermatolog Treat 2006; 17:158.
  32. Vounotrypidis P, Sakellariou GT, Zisopoulos D, Berberidis C. Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra). Rheumatology (Oxford) 2006; 45:491.
  33. Handler RP. Leflunomide for relapsing polychondritis: successful longterm treatment. J Rheumatol 2006; 33:1916; author reply 1916.
  34. Trentham DE, Dynesius-Trentham RA. Antibiotic therapy for rheumatoid arthritis. Scientific and anecdotal appraisals. Rheum Dis Clin North Am 1995; 21:817.
  35. Peng SL, Rodriguez D. Abatacept in relapsing polychondritis. Ann Rheum Dis 2013; 72:1427.
  36. Leroux G, Costedoat-Chalumeau N, Brihaye B, et al. Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients. Arthritis Rheum 2009; 61:577.
  37. Gaffney RJ, Harrison M, Blayney AW. Nebulized racemic ephedrine in the treatment of acute exacerbations of laryngeal relapsing polychondritis. J Laryngol Otol 1992; 106:63.
  38. Carrión M, Girón JA, Ventura J, et al. Airway complications in relapsing polychondritis. J Rheumatol 1993; 20:1628.
  39. Adliff M, Ngato D, Keshavjee S, et al. Treatment of diffuse tracheomalacia secondary to relapsing polychondritis with continuous positive airway pressure. Chest 1997; 112:1701.
  40. Eng J, Sabanathan S. Airway complications in relapsing polychondritis. Ann Thorac Surg 1991; 51:686.
  41. Dunne JA, Sabanathan S. Use of metallic stents in relapsing polychondritis. Chest 1994; 105:864.
  42. Faul JL, Kee ST, Rizk NW. Endobronchial stenting for severe airway obstruction in relapsing polychondritis. Chest 1999; 116:825.
  43. Sarodia BD, Dasgupta A, Mehta AC. Management of airway manifestations of relapsing polychondritis: case reports and review of literature. Chest 1999; 116:1669.
  44. Ishikawa S, Yamazaki M, Takei Y, et al. [A case of relapsing polychondritis with oculobulbar symptoms and successful treatment of respiratory failure with BiPAP]. Rinsho Shinkeigaku 1999; 39:1040.
  45. Lehman JD, Gordon RL, Kerlan RK Jr, et al. Expandable metallic stents in benign tracheobronchial obstruction. J Thorac Imaging 1998; 13:105.
  46. Niwa H, Masaoka A, Yamakawa Y, et al. Esophageal tracheobronchoplasty for diseases of the central airway. J Thorac Cardiovasc Surg 1996; 112:124.
  47. Sacco O, Fregonese B, Oddone M, et al. Severe endobronchial obstruction in a girl with relapsing polychondritis: treatment with Nd YAG laser and endobronchial silicon stent. Eur Respir J 1997; 10:494.
  48. Spraggs PD, Tostevin PM, Howard DJ. Management of laryngotracheobronchial sequelae and complications of relapsing polychondritis. Laryngoscope 1997; 107:936.
  49. Lang-Lazdunski L, Hvass U, Paillole C, et al. Cardiac valve replacement in relapsing polychondritis. A review. J Heart Valve Dis 1995; 4:227.
  50. Lang-Lazdunski L, Pansard Y, Hvass U. Aortic valve replacement in relapsing polychondritis. J Thorac Cardiovasc Surg 1997; 114:131.
  51. Del Rosso A, Petix NR, Pratesi M, Bini A. Cardiovascular involvement in relapsing polychondritis. Semin Arthritis Rheum 1997; 26:840.
  52. Dib C, Moustafa SE, Mookadam M, et al. Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin Proc 2006; 81:772.
  53. Biro P, Rohling R, Schmid S, et al. Anesthesia in a patient with acute respiratory insufficiency due to relapsing polychondritis. J Clin Anesth 1994; 6:59.
  54. Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104:74.
  55. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976; 55:193.
  56. Cohen PR, Rapini RP. Relapsing polychondritis. Int J Dermatol 1986; 25:280.